TORONTO – May 21, 2024 – Innovation is not just a trendy buzz word to the Canadian Nuclear Isotope Council’s (CNIC) newest member, Nuclear Promise X (NPX). Instead, it is the very foundation of all their work as they continue to distance themselves as a change leader, helping to push the nuclear industry further into … Read more
Toronto – May 15, 2024– NUCM, a Canadian company that produces GMP Radiopharmaceuticals crucial for medical imaging and treatments, has joined the Canadian Nuclear Isotope Council (CNIC). NUCM is a source for all commonly-used Tc-99m SPECT radiopharmaceuticals and continue to expand their production to additional customized Theranostic Radiopharmaceuticals, and new PET products containing Gallium-68. NUCM … Read more
TORONTO – May 9, 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to announce the addition of Novartis Canada as its newest member. As an innovative medicines company focused on addressing significant areas of unmet medical need, Novartis Canada is well placed to help the CNIC in its efforts to ensure that novel … Read more
Toronto – May 1 2024 – Since its inception, the Canadian Nuclear Isotope Council (CNIC) has been focused on establishing itself as the pre-eminent thought leader for Canadian isotopes through the delivery of authentic and genuine content that leverages the expertise, insight, and experience of the sector and its members to educate the public. Today, … Read more
TORONTO – April 17, 2024 – For decades, Canada has been a prominent global leader in the production and supply of isotopes that play a major role in many aspects of our daily lives. To maintain, protect, and grow this leadership into the future, we must ensure that we are training sufficient personnel with the … Read more
TORONTO – April 15, 2024 – Since its creation over six years ago, the Canadian Nuclear Isotope Council (CNIC) has been committed to advocating on behalf of Canada’s isotope industry and nuclear medicine community. Today, CNIC is excited to announce the addition of the Canadian Association of Medical Radiation Technologists (CAMRT) as its newest industry … Read more
Toronto – March 11, 2024 – As the voice of Canada’s isotope industry, the Canadian Nuclear Isotope Council (CNIC) aims to drive and strengthen Canada’s isotope sector through innovation, leadership, and collaboration. CNIC represents Canada’s nuclear isotope infrastructure, research institutions, medical community, and specialized companies and organizations across the country. In support of its vision … Read more
Ottawa – February 28, 2023 – At the Canadian Nuclear Association annual conference, the Canadian Nuclear Isotope Council (CNIC) was pleased to gather leaders in the isotope industry for the 2023 CNIC Awards Reception, hosted by iPolitics. The CNIC Awards provide an annual platform to recognize the ongoing growth and success of CNIC and its … Read more
Toronto – January 3, 2023 – Nuclear Promise X (NPX) and The Canadian Nuclear Isotope Council (CNIC) are excited to announce a collaboration to explore the feasibility of producing isotopes that will be leveraged for Deep Space Exploration applications. This collaboration will see the NPX and CNIC performing a study for the Canadian Space Agency (CSA) … Read more
Toronto – December 7 2023 – In support of Canadian Nuclear Isotope Council’s (CNIC) goal of ensuring a reliable supply of medical isotopes for patients and doubling Canada’s production of isotopes by 2030, CNIC is excited to welcome Actineer to its growing membership. Formed in October 2023, Actineer is a joint venture company between Canadian … Read more